Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 2Phase 4 1Phase 3 1

Status

Unknown 204Completed 93Recruiting 80Not yet recruiting 60Terminated 20Active not recruiting 10Withdrawn 8Enrolling by invitation 5Suspended 2

Sponsor Class

OTHER 63INDUSTRY 17NIH 8OTHER_GOV 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Congenital Abnormalities 1

Interventions

zanubrutinib 1Vincristine 1Rituximab 1Prednisone 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Suspended × OTHER_GOV × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

NCT01356303 2016-05-13

TAXIS01

National Guard Health Affairs

Phase 2 Suspended
50 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡